A new curcumin-based compound slowed brain tumor growth in lab tests
Original title: Novel curcumin derivative DMC-GF suppresses glioblastoma growth by targeting MAPK1 and TRIM21 to modulates STAT3/AKT phosphorylation.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in cells in the lab and in mice.
The short version
A new compound called DMC-GF slowed glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary growth in cells and in mice, but it has not been tested in people.
What was studied. Researchers made a new compound from curcumin, called DMC-GF. They tested it on glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells in the lab and in mice with brain tumors.
What they found. DMC-GF slowed the growth of glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells. It also caused the tumor cells to die. In the mice, it held back tumor growth. The team also looked at how it works inside the cell, and found it acts on certain proteins and on the way cells make energy.
What this means, and what it doesn't
What it could mean: This gives scientists a new compound to study for glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. It points to how the compound may work against tumor cells. For now, it is a starting point for more research, not a treatment you can ask for.
What it doesn't mean: This does not mean there is a new treatment. The work was done in cells and in mice only. No people were treated with DMC-GF in this study. Many things that work in mice do not work in people. It is a long way from everyday care, and it is not a promise of a cure.
Source: PubMed, July 31, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.